Imexpharm Corp 2024 SR
The report highlights Imexpharm's sustainability performance and strategic progress in 2024 under the theme 'Connecting Science - Elevating Health.' The company achieved a gross revenue of VND 2,512.8 billion, representing an 18.9% increase year-on-year, while investing 5% of its revenue into research and development. Imexpharm successfully maintained its leading position in Vietnam's pharmaceutical industry with 12 EU-GMP certified production lines. On the environmental front, the company reduced its wastewater volume by 25.1% and hazardous waste by 4.5% through advanced treatment systems and strategic partnerships. Additionally, Imexpharm was recognized as the top workplace in Vietnam's pharmaceutical sector and continued its strong commitment to community development and transparent corporate governance.
Company: Imexpharm Corp
Sector: Health Care
Country: Vietnam
Year: 2024
Type: SR
Pages: 124
Imexpharm Corp
Sustainability Report
The report highlights Imexpharm's sustainability performance and strategic progress in 2024 under the theme 'Connecting Science - Elevating Health.' The company achieved a gross revenue of VND 2,512.8 billion, representing an 18.9% increase year-on-year, while investing 5% of its revenue into research and development. Imexpharm successfully maintained its leading position in Vietnam's pharmaceutical industry with 12 EU-GMP certified production lines. On the environmental front, the company reduced its wastewater volume by 25.1% and hazardous waste by 4.5% through advanced treatment systems and strategic partnerships. Additionally, Imexpharm was recognized as the top workplace in Vietnam's pharmaceutical sector and continued its strong commitment to community development and transparent corporate governance.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Energy Consumption
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees